cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.15468/dl.f7b882
title: Occurrence Download

description: A dataset containing 3722 species occurrences available in GBIF matching the query:
{
 "and" : [
 "Continent is North America",
 "OccurrenceStatus is Present",
 "TaxonKey is one of (Ribes oxyacanthoides L., Ribes oxyacanthoides Michx., Ribes oxyacanthoides Georgi)"
 ]
}

 The dataset includes 3722 records from 108 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0011830-250426092105405/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.ntmztd
title: Occurrence Download

description: A dataset containing 9929058 species occurrences available in GBIF matching the query:
{
 "and" : [
 "Geometry POLYGON((-21 18,10 18,10 61,-21 61,-21 18))",
 "HasCoordinate is true",
 "HasGeospatialIssue is false",
 "TaxonKey is Coleoptera",
 "Year 1975-2025"
 ]
}

 The dataset includes 9929058 records from 5657 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0011819-250426092105405/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.3535/6ph-6me-wjh
title: Foraminifera d'Orbigny, 1826

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.
DOI: 10.6084/m9.figshare.29940572
title: Supplementary Material for: Real-world Treatment Patterns and Clinical Outcomes in Patients with Unresectable Hepatocellular Carcinoma: Results from the OREIOS Study

description: Background
OREIOS (NCT05239507) study determined the clinical characteristics, management patterns, and survival outcomes in patients with unresectable HCC (uHCC) from 12 countries across Asia, Latin America, and Middle East and Africa.

Methods
This non-interventional, retrospective study enrolled patients with Barcelona Clinic Liver Cancer (BCLC) stage B or C unresectable or advanced/metastatic HCC at index date, diagnosed between January 2017 and December 2019. The primary outcomes were median overall survival (mOS) and landmark survival (12 and 24 months) and secondary outcomes were clinicodemographic characteristics, treatment patterns, and median progression-free survival (mPFS).

Results 
A total of 1116 patients (median [range] age: 63.0 [18.0-97.0] years) were recruited; 83.2% (929/1116) were males, 49.5% (422/852) were current/ex-smokers, and 21.3% (122/572) consumed alcohol. At the index date, 22.3% (249/1116) and 77.7% (867/1116) of patients presented with BCLC stage B and C, respectively, with main portal vein invasion in 23.5% (263/1116), &gt;50% liver involvement in 23.1% (250/1082), and extrahepatic metastases in 48.5% (541/1116). Transarterial chemoembolization was performed before and after the index dates in 22.9% (255/1112) and 20.8% (232/1116) of patients, respectively. In the first-line of therapy (LOT), majority of patients received tyrosine multikinase inhibitors (TKIs)─ sorafenib (68.3% [684/1002] and lenvatinib (10.2% [102/1002]). Irrespective of LOT, the mPFS and mOS was 6.1 (95% CI: 5.5-6.7) and 13.1 (95% CI: 11.6, 14.1) months for the overall cohort. The survival rate at 12 and 24months for the overall cohort were52.1 % (95% CI: 49.1-55.1) and 30.6% (95% CI: 27.8-33.4).

Conclusion
Our study provides retrospective view of treatment strategies in patients with advanced uHCC prior to advent of immunotherapy and combination therapy. Majority of patients received TKIs, as per then recommended and available treatment options. The mOS in our study was similar to that observed in pivotal clinical trials for TKIs. With novel agents and combination therapies being approved for uHCC, integrating them into routine care is important to improve survival.
DOI: 10.6084/m9.figshare.29940572.v1
title: Supplementary Material for: Real-world Treatment Patterns and Clinical Outcomes in Patients with Unresectable Hepatocellular Carcinoma: Results from the OREIOS Study

description: Background
OREIOS (NCT05239507) study determined the clinical characteristics, management patterns, and survival outcomes in patients with unresectable HCC (uHCC) from 12 countries across Asia, Latin America, and Middle East and Africa.

Methods
This non-interventional, retrospective study enrolled patients with Barcelona Clinic Liver Cancer (BCLC) stage B or C unresectable or advanced/metastatic HCC at index date, diagnosed between January 2017 and December 2019. The primary outcomes were median overall survival (mOS) and landmark survival (12 and 24 months) and secondary outcomes were clinicodemographic characteristics, treatment patterns, and median progression-free survival (mPFS).

Results 
A total of 1116 patients (median [range] age: 63.0 [18.0-97.0] years) were recruited; 83.2% (929/1116) were males, 49.5% (422/852) were current/ex-smokers, and 21.3% (122/572) consumed alcohol. At the index date, 22.3% (249/1116) and 77.7% (867/1116) of patients presented with BCLC stage B and C, respectively, with main portal vein invasion in 23.5% (263/1116), &gt;50% liver involvement in 23.1% (250/1082), and extrahepatic metastases in 48.5% (541/1116). Transarterial chemoembolization was performed before and after the index dates in 22.9% (255/1112) and 20.8% (232/1116) of patients, respectively. In the first-line of therapy (LOT), majority of patients received tyrosine multikinase inhibitors (TKIs)─ sorafenib (68.3% [684/1002] and lenvatinib (10.2% [102/1002]). Irrespective of LOT, the mPFS and mOS was 6.1 (95% CI: 5.5-6.7) and 13.1 (95% CI: 11.6, 14.1) months for the overall cohort. The survival rate at 12 and 24months for the overall cohort were52.1 % (95% CI: 49.1-55.1) and 30.6% (95% CI: 27.8-33.4).

Conclusion
Our study provides retrospective view of treatment strategies in patients with advanced uHCC prior to advent of immunotherapy and combination therapy. Majority of patients received TKIs, as per then recommended and available treatment options. The mOS in our study was similar to that observed in pivotal clinical trials for TKIs. With novel agents and combination therapies being approved for uHCC, integrating them into routine care is important to improve survival.
DOI: 10.3535/7rg-3kl-hsg
title: †Fusulinidae Möller, 1878

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.
DOI: 10.3535/c77-z0s-yk3
title: †Linderina Schlumberger, 1893

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.
DOI: 10.3535/063-k7q-fls
title: Nummulitidae Blainville, 1827

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.
DOI: 10.3535/bvt-b4v-q2y
title: †Lepidocyclina Gümbel, 1870

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.
DOI: 10.6084/m9.figshare.29940578
title: Supplementary Material for: Immunotherapy-related pancreatitis: a case series of eight patients from a high-volume oncology centre

description: Introduction
Immune checkpoint inhibitors (ICIs) may lead to immune-related adverse events (irAEs), including the rare complication of immune-related acute pancreatitis (irAP). Current knowledge about irAP is limited to case reports and retrospective studies. 

Case Presentations
We retrospectively reviewed eight patients diagnosed with irAP at a high-volume tertiary cancer centre in Chile between 2021 and 2025. Data were collected on cancer type, immunotherapy regimen, symptoms, enzyme levels, imaging, and treatment. The irAP diagnosis was established according to the American Gastroenterological Association criteria. Adverse reactions were graded using CTCAE v5.0.
Of the eight included patients, four had melanoma, two had breast cancer, and two prostate cancer. Seven received PD-1/CTLA-4 combination therapy, and one received anti-PD-1 monotherapy. The median time to the irAP diagnosis was 5 months. Seven patients presented with gastrointestinal symptoms. Enzyme elevations and imaging findings were variable. All patients were treated with systemic corticosteroids, and three required hospitalisation. Four patients were rechallenged with ICIs. Other grade ≥2 irAEs were observed in six patients. No deaths were directly attributable to irAP.

Conclusion
As demonstrated, these manifestations can diverge substantially from those of classical pancreatitis, so establishing an irAP diagnosis requires a comprehensive assessment. Corticosteroids are an effective treatment in most cases, and ICI rechallenge may be feasible in selected patients. This case series adds eight new reports to the limited literature on irAP, underscoring its clinical heterogeneity and the need for tailored management. Further research and detailed case reporting are essential to improve diagnosis and treatment of this rare toxicity.
DOI: 10.6084/m9.figshare.29940578.v1
title: Supplementary Material for: Immunotherapy-related pancreatitis: a case series of eight patients from a high-volume oncology centre

description: Introduction
Immune checkpoint inhibitors (ICIs) may lead to immune-related adverse events (irAEs), including the rare complication of immune-related acute pancreatitis (irAP). Current knowledge about irAP is limited to case reports and retrospective studies. 

Case Presentations
We retrospectively reviewed eight patients diagnosed with irAP at a high-volume tertiary cancer centre in Chile between 2021 and 2025. Data were collected on cancer type, immunotherapy regimen, symptoms, enzyme levels, imaging, and treatment. The irAP diagnosis was established according to the American Gastroenterological Association criteria. Adverse reactions were graded using CTCAE v5.0.
Of the eight included patients, four had melanoma, two had breast cancer, and two prostate cancer. Seven received PD-1/CTLA-4 combination therapy, and one received anti-PD-1 monotherapy. The median time to the irAP diagnosis was 5 months. Seven patients presented with gastrointestinal symptoms. Enzyme elevations and imaging findings were variable. All patients were treated with systemic corticosteroids, and three required hospitalisation. Four patients were rechallenged with ICIs. Other grade ≥2 irAEs were observed in six patients. No deaths were directly attributable to irAP.

Conclusion
As demonstrated, these manifestations can diverge substantially from those of classical pancreatitis, so establishing an irAP diagnosis requires a comprehensive assessment. Corticosteroids are an effective treatment in most cases, and ICI rechallenge may be feasible in selected patients. This case series adds eight new reports to the limited literature on irAP, underscoring its clinical heterogeneity and the need for tailored management. Further research and detailed case reporting are essential to improve diagnosis and treatment of this rare toxicity.
DOI: 10.3535/fx4-bt7-w87
title: †Lepidocyclina Gümbel, 1870

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.
DOI: 10.3535/g4a-alt-fr6
title: Ostracoda Latreille, 1802

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.
DOI: 10.3535/hal-2av-t8z
title: Foraminifera d'Orbigny, 1826

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.
DOI: 10.3535/yjk-2hj-yj9
title: Planorbulina d'Orbigny, 1826

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.
DOI: 10.3535/fgt-le8-c53
title: Foraminifera d'Orbigny, 1826

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.
DOI: 10.6084/m9.figshare.29940581
title: Supplementary Material for: Incidental Gallbladder Carcinoma Discovered During Living Liver Donor Evaluation

description: Introduction
Gallbladder cancer (GBC) is the most common and aggressive malignancy of the biliary tract, often diagnosed at an advanced stage with a poor prognosis due to its typically insidious onset and nonspecific symptoms. Early-stage GBC is usually asymptomatic and most frequently discovered incidentally following cholecystectomy for presumed benign disease. This case report details the rare incidental discovery of GBC in a potential living liver donor, an individual significantly younger than the typical demographic for this cancer, highlighting the value of comprehensive donor screening protocols.

Case Presentation
A 45-year-old, asymptomatic Arab female with no significant medical history was evaluated as a potential living liver donor for her brother. Routine preoperative imaging revealed marked gallbladder wall thickening, a solitary gallstone larger than 3 cm, and a suspicious mass extending into the liver. A subsequent PET/CT scan confirmed an FDG-avid lesion localized to the gallbladder and adjacent liver, with no evidence of distant metastasis. The patient underwent an open en bloc resection of the gallbladder with hepatic segments IVb and V. Histopathological examination confirmed a moderately differentiated adenocarcinoma (pT2bN1M0, Stage IIIB). The patient recovered well postoperatively and completed six cycles of adjuvant chemotherapy. At a three-year follow-up, she remains asymptomatic with no evidence of disease recurrence.

Conclusion
This case represents a unique and valuable contribution to the medical literature, documenting a rare incidental finding of gallbladder carcinoma in an asymptomatic living liver donor candidate. The rigorous screening protocols standard for living organ donation proved to be life-saving by uncovering an occult malignancy at a treatable stage. This report underscores the importance of maintaining a high index of suspicion for any gallbladder abnormalities detected during donor evaluation and serves as a critical reference for transplant, surgical, and oncology teams.
DOI: 10.6084/m9.figshare.29940581.v1
title: Supplementary Material for: Incidental Gallbladder Carcinoma Discovered During Living Liver Donor Evaluation

description: Introduction
Gallbladder cancer (GBC) is the most common and aggressive malignancy of the biliary tract, often diagnosed at an advanced stage with a poor prognosis due to its typically insidious onset and nonspecific symptoms. Early-stage GBC is usually asymptomatic and most frequently discovered incidentally following cholecystectomy for presumed benign disease. This case report details the rare incidental discovery of GBC in a potential living liver donor, an individual significantly younger than the typical demographic for this cancer, highlighting the value of comprehensive donor screening protocols.

Case Presentation
A 45-year-old, asymptomatic Arab female with no significant medical history was evaluated as a potential living liver donor for her brother. Routine preoperative imaging revealed marked gallbladder wall thickening, a solitary gallstone larger than 3 cm, and a suspicious mass extending into the liver. A subsequent PET/CT scan confirmed an FDG-avid lesion localized to the gallbladder and adjacent liver, with no evidence of distant metastasis. The patient underwent an open en bloc resection of the gallbladder with hepatic segments IVb and V. Histopathological examination confirmed a moderately differentiated adenocarcinoma (pT2bN1M0, Stage IIIB). The patient recovered well postoperatively and completed six cycles of adjuvant chemotherapy. At a three-year follow-up, she remains asymptomatic with no evidence of disease recurrence.

Conclusion
This case represents a unique and valuable contribution to the medical literature, documenting a rare incidental finding of gallbladder carcinoma in an asymptomatic living liver donor candidate. The rigorous screening protocols standard for living organ donation proved to be life-saving by uncovering an occult malignancy at a treatable stage. This report underscores the importance of maintaining a high index of suspicion for any gallbladder abnormalities detected during donor evaluation and serves as a critical reference for transplant, surgical, and oncology teams.
DOI: 10.3535/s54-e5z-b4l
title: Animalia

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.
DOI: 10.3535/td7-jyr-dtb
title: Foraminifera d'Orbigny, 1826

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.
DOI: 10.3535/jcw-lyq-9sk
title: †Lepidocyclina Gümbel, 1870

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.
DOI: 10.3535/w4q-kvy-gnn
title: †Lepidorbitoides Silvestri, 1907

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.
DOI: 10.3535/7xe-rg6-4ej
title: †Lepidocyclina Gümbel, 1870

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.
DOI: 10.3535/epg-wpq-de3
title: †Lepidocyclina Gümbel, 1870

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.
DOI: 10.3535/wfd-h1x-vf0
title: †Lepidocyclina Gümbel, 1870

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.
DOI: 10.15468/dl.zcnwd4
title: Occurrence Download

description: A dataset containing 0 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is Penaeus monodon",
 "Country is Fiji",
 "HasCoordinate is true"
 ]
}

 The dataset includes 0 records from 0 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0022676-250811113504898/datasets/export for details.
DOI: 10.3535/3k8-45p-8ej
title: Bos taurus Linnaeus, 1758

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.
DOI: 10.3535/g14-yfb-cvf
title: Isurus

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.
DOI: 10.3535/n58-c5r-5h0
title: Cassidula A. Férussac, 1821

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.
DOI: 10.3535/t0r-g08-f62
title: Animalia

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.
DOI: 10.3535/8a1-ync-21p
title: †Meekoceras planulatum (de Koninck, 1863)

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.
DOI: 10.3535/wql-jg0-lh6
title: Animalia

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.
DOI: 10.3535/bfk-3pd-tb0
title: Foraminifera d'Orbigny, 1826

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.
DOI: 10.3535/214-5x6-ts0
title: Sphincterochila Ancey, 1887

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.
DOI: 10.3535/k6k-190-4tw
title: Cetacea Brisson, 1762

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.
DOI: 10.3535/18b-2hl-dzl
title: Porifera Grant, 1836

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.
DOI: 10.3535/yz1-3xp-9hw
title: †Lepidocyclina Gümbel, 1870

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.
DOI: 10.3535/3rb-v9f-p7z
title: Animalia

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.
DOI: 10.3535/m7b-spn-9l7
title: †Lepidocyclina Gümbel, 1870

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.
DOI: 10.3535/077-njp-1d8
title: Porocara Sloane, 1917

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.
DOI: 10.3535/k64-y71-3ef
title: †Cellaria crassa Wood, 1844

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.
DOI: 10.3535/q32-537-wpv
title: Foraminifera d'Orbigny, 1826

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.
DOI: 10.3535/73p-w3p-vsc
title: †Fusulinidae Möller, 1878

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.
DOI: 10.3535/snx-81h-b5q
title: Eponides Montfort, 1808

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.
DOI: 10.3535/1y5-zfs-3hs
title: Animalia

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.
DOI: 10.3535/cyl-8yh-hl4
title: †Kathina Smout, 1954

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.
DOI: 10.3535/lce-c6n-n2k
title: Animalia

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.
DOI: 10.3535/n8l-pg7-bfy
title: Foraminifera d'Orbigny, 1826

description: Digital Specimen for the physical specimen hosted at Naturalis Biodiversity Center.
DOI: 10.15468/dl.zrv2zj
title: Occurrence Download

description: A dataset containing 4 species occurrences available in GBIF matching the query:
{
 "and" : [
 {
 "and" : [
 "HasGeospatialIssue is false",
 "HasCoordinate is true",
 "OccurrenceStatus is Present",
 {
 "not" : {
 "BasisOfRecord" : [
 "is one of (Fossil, Living Specimen)"
 ]
 }
 }
 ]
 },
 "TaxonKey is Mannophryne lamarcai Mijares-Urrutia & Arends-R., 1999"
 ]
}

 The dataset includes 4 records from 1 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0021635-240229165702484/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.e9mrd3
title: Occurrence Download

description: A dataset containing 928 species occurrences available in GBIF matching the query:
{
 "and" : [
 "BasisOfRecord is one of (Observation, Machine Observation, Human Observation, Material sample, Material citation, Specimen, Occurrence evidence)",
 "Country is Greece",
 "OccurrenceStatus is Present",
 "TaxonKey is Myiopsitta monachus (Boddaert, 1783)",
 "Year 1990-2022"
 ]
}

 The dataset includes 928 records from 5 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0066544-230224095556074/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.mst3j7
title: Occurrence Download

description: A dataset containing 3 species occurrences available in GBIF matching the query:
{
 "and" : [
 "TaxonKey is one of (Oxyconger leptognathus, Oxyconger leptognathus, Oxyconger leptognathus (Bleeker, 1858), Oxyconger leptognathus (Bleeker, 1858), Oxyconger leptognathus (Bleeker, 1858), Oxyconger leptognathus (Bleeker, 1858), Oxyconger leptognathus (Bleeker, 1858), Oxyconger leptognathus (Bleeker, 1858), Oxyconger leptognathus (Bleeker, 1858), 158164367, Oxyconger leptognathus (Bleeker, 1858), Oxyconger leptognathus (Bleeker 1857) Bleeker 1857, Congresox talabon (Cuvier, 1829), Congresox talabon (Cuvier 1829) Cuvier 1829, Conger leptognathus Bleeker, 1858, Conger leptognathus Bleeker, 1858, Conger leptognathus Bleeker, 1858, Conger leptognathus Bleeker, 1858, 196561475)",
 "BasisOfRecord is one of (Specimen, Human Observation, Observation, Living Specimen, Machine Observation, Literature Occurrence)",
 "Geometry POLYGON((105.5 17,110.5 17,110.5 22,105.5 22,105.5 17))",
 "HasCoordinate is true",
 "HasGeospatialIssue is false"
 ]
}

 The dataset includes 3 records from 1 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0250394-220831081235567/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.15468/dl.2ezatr
title: Occurrence Download

description: A dataset containing 10694 species occurrences available in GBIF matching the query:
{
 "TaxonKey" : [
 "is Lagopus leucura (Richardson, 1831)"
 ]
}

 The dataset includes 10694 records from 73 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0363684-210914110416597/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.